Premium
Human papillomavirus and nasopharyngeal cancer
Author(s) -
Verma Vivek,
Simone Charles B.,
Lin Chi
Publication year - 2018
Publication title -
head and neck
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.012
H-Index - 127
eISSN - 1097-0347
pISSN - 1043-3074
DOI - 10.1002/hed.24978
Subject(s) - medicine , oncology , proportional hazards model , human papillomavirus , logistic regression , cancer , propensity score matching , hpv infection , disease , cervical cancer
Background There are no existing high‐volume studies characterizing human papillomavirus (HPV)‐associated nasopharyngeal cancer (NPC). Methods The National Cancer Data Base (NCDB) was queried for NPC with known HPV (2004‐2013). Logistic regression ascertained factors associated with HPV‐positivity. Kaplan‐Meier overall survival (OS) was evaluated between HPV‐positive and HPV‐negative cohorts; Cox proportional hazards modeling assessed factors associated with OS. Patients with nonmetastatic disease receiving definitive chemoradiotherapy underwent propensity‐matched OS analysis. Results Altogether, 956 patients were analyzed (32% HPV‐positive and 68% HPV‐negative). Median follow‐up was 23 months (range 0‐67 months). The patients with HPV‐positive disease were younger, less likely to be uninsured, lived in more educated areas, and presented with more advanced T (but not N/overall) classification. Median OS for HPV‐positive and HPV‐negative groups were 50 and 43 months, respectively ( P = .171). The HPV status did not independently predict for OS ( P = .183). No OS differences were observed after propensity matching ( P = .734). Conclusion In what we believe as the only large study of HPV‐associated NPC, HPV neither correlates with nor predicts survival in NPC. Owing to the difficulty of addressing causality in database studies, further work must corroborate the findings herein.